- MDXH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
MDxHealth (MDXH) CORRESPCorrespondence with SEC
Filed: 1 Nov 21, 12:00am
November 1, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada Sarmento and Jeffrey Gabor
Re: | MDxHealth SA Registration Statement on Form F-1 File No. 333-260213 |
Acceleration Request
Requested Date: | November 3, 2021 |
Requested Time: | 4:30 p.m., Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MDxHealth SA hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement to 4:30 p.m., Eastern Time, on November 3, 2021, or as soon thereafter as practicable or at such later time as the Company may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Please confirm once the Registration Statement has been declared effective by calling Mark Busch of K&L Gates LLP at (704) 331-7440. Please also contact him should you have any questions.
/s/ Michael McGarrity | |
Michael McGarrity | |
Chief Executive Officer |
cc:
Mark R. Busch, Esq.
K&L Gates LLP